AQR Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
1,473,812
+1,081,257
| +275% | +$4.14M | ﹤0.01% | 1216 |
|
|
2025
Q1 | $2.26M | Buy |
392,555
+321,992
| +456% | +$1.85M | ﹤0.01% | 1540 |
|
|
2024
Q4 | $352K | Buy |
+70,563
| New | +$352K | ﹤0.01% | 2428 |
|
|
2024
Q3 | – | Sell |
-34,781
| Closed | -$115K | – | 2756 |
|
|
2024
Q2 | $115K | Sell |
34,781
-70,273
| -67% | -$233K | ﹤0.01% | 2485 |
|
|
2024
Q1 | $344K | Buy |
+105,054
| New | +$344K | ﹤0.01% | 2093 |
|
|
2023
Q4 | – | Sell |
-20,913
| Closed | -$140K | – | 2327 |
|
|
2023
Q3 | $140K | Sell |
20,913
-5,245
| -20% | -$35K | ﹤0.01% | 2188 |
|
|
2023
Q2 | $219K | Buy |
+26,158
| New | +$219K | ﹤0.01% | 2060 |
|
|
2022
Q3 | – | Sell |
-40,954
| Closed | -$163K | – | 2178 |
|
|
2022
Q2 | $163K | Buy |
+40,954
| New | +$163K | ﹤0.01% | 2018 |
|
|
2021
Q3 | – | Sell |
-22,629
| Closed | -$256K | – | 2238 |
|
|
2021
Q2 | $256K | Buy |
+22,629
| New | +$256K | ﹤0.01% | 2086 |
|
|
2019
Q2 | – | Sell |
-20,145
| Closed | -$182K | – | 2057 |
|
|
2019
Q1 | $182K | Buy |
20,145
+7,171
| +55% | +$64.8K | ﹤0.01% | 2084 |
|
|
2018
Q4 | $108K | Buy |
+12,974
| New | +$108K | ﹤0.01% | 2144 |
|